| Literature DB >> 36051589 |
Min Liu1, Meitong Huo1, Changshui Liu2, Likun Guo1, Yamei Ding2, Qingjun Ma2, Qingsheng Qi1, Mo Xian3, Guang Zhao1,3.
Abstract
As an evolutionarily conserved posttranslational modification, protein lysine acetylation plays important roles in many physiological and metabolic processes. However, there are few reports about the applications of lysine acetylation in metabolic regulations. Lactate is a main byproduct in microbial fermentation, and itself also an important bulk chemical with considerable commercial values in many fields. Lactate dehydrogenase (LdhA) is the key enzyme catalyzing lactate synthesis from pyruvate. Here, we reported that Escherichia coli LdhA can be acetylated and the acetylated lysine sites were identified by mass spectrometry. The effects and regulatory mechanisms of acetylated sites on LdhA activity were characterized. Finally, lysine acetylation was successfully used to regulate the lactate synthesis. LdhA (K9R) mutant overexpressed strain improved the lactate titer and glucose conversion efficiency by 1.74 folds than that of wild-type LdhA overexpressed strain. LdhA (K154Q-K248Q) mutant can inhibit lactate accumulation and improve 3HP production. Our study established a paradigm for lysine acetylation in lactate synthesis regulation and suggested that lysine acetylation may be a promising strategy to improve the target production and conversion efficiency in microbial synthesis. The application of lysine acetylation in regulating lactate synthesis also provides a reference for the treatment of lactate-related diseases.Entities:
Keywords: enzyme activity; lactate dehydrogenase A; lactate synthesis; lysine acetylation; metabolic engineering
Year: 2022 PMID: 36051589 PMCID: PMC9424733 DOI: 10.3389/fbioe.2022.966062
Source DB: PubMed Journal: Front Bioeng Biotechnol ISSN: 2296-4185
Plasmids and strains used in this study.
| Plasmids and strains | Relevant properties | Source |
|---|---|---|
| Plasmids | ||
| pACYCDuet1 |
| Novagen |
| pETDuet1 | Ampr oriPBR322 lacIq PT7 | Novagen |
| pCP20 | reppSC101ts ApR CmR cI857 λPR FLP | CGSC |
| pRE112 | oriT oriV sacB CmR | Dr. Roy Curtiss III |
| pACYCDuet1- | repp15A CmR lacI PT7
|
|
| pETDuet1- | reppBR322 AmpR lacI Plac,p2-51 - |
|
| pETDuet1- | Ampr oriPBR322 lacIq PT7 ldhA | This study |
| Strains | ||
| | F−
| Invitrogen |
| | F−
| Invitrogen |
| |
| Dr. Roy Curtiss III |
| Q3685 |
| This study |
| Q3749 |
| This study |
| Q3750 |
| This study |
| Q3686 |
| This study |
| Q3687 |
| This study |
| Q3688 |
| This study |
| Q3689 |
| This study |
| Q3690 |
| This study |
| Q3691 |
| This study |
| Q3714 |
| This study |
| Q3715 |
| This study |
| Q3719 |
| This study |
| Q3720 |
| This study |
| Q3786 |
| This study |
| Q3787 |
| This study |
| JW1375 | BW25113 | Keio collection |
| Q2326 |
| This study |
| Q3784 |
| This study |
| Q3785 |
| This study |
| Q3790 |
| This study |
| Q2191 |
| This study |
| Q 3824 | Q2326 | This study |
| Q 3825 | Q3790 | This study |
The Coli Genetic Stock Center at Yale University.
FIGURE 1LdhA acetylation and enzyme activity in LB with 2% glucose cultivated condition. (A) SDS-PAGE and western blot analysis of LdhA cultivated in different conditions. (B) LdhA activity in cells grown in LB broth with and without 2% glucose supplementation. (C) SDS-PAGE and western blot analysis of LdhA variants with lysine substitution. (D) The enzyme activities of LdhA variants with lysine substitution.
Identification of acetylated LdhA peptides by mass spectrometry.
| Site | Sequence |
|---|---|
| K9 | LAVYSTK(Ac)QYDK |
| K70 | HGVK(Ac)YIALR |
| K154 | TAGVIGTGK(Ac)IGVAMLR |
| K248 | IDSQAAIEALK(Ac)NQKIGSLGMD |
FIGURE 2The 3D modelled structure of EcLdhA. (A) Quaternary structures of LdhA. (B) Location of the LdhA acetylated lysine sites, K70 is located at the distal region of the catalytic domain, K154 is responsible for binding the cofactor of NADH, K9 and K248 form the salt bridges with acidic amino acids, Pyr: pyruvate.
FIGURE 3The mechanism of K9 acetylation on enzyme activity. (A) The salt bridge of K9-E269 in monomer. (B) The acetylation levels of E269 mutants. (C) The enzyme activities of E269 mutants.
FIGURE 4The mechanism of K248 acetylation on enzyme activity. (A) The intermonomer salt bridge of K248-D279. (B) The acetylation levels of D279 mutants. (C) The enzyme activities of D279 mutants. (D) Size exclusion chromatograph of LdhA mutants about the K248-D279 salt bridge.
FIGURE 5LdhA acetylation and enzyme activity in LB cultivated condition. (A) SDS-PAGE and western blot analysis of LdhA variants with lysine substitution. (B) The enzyme activities of LdhA variants with lysine substitution.
FIGURE 6K9R mutant improves lactate production. (A) The cell growth and glucose consumption of wild LdhA and K9R mutant overexpressed strains. The yellow line represents the cell growth, the blue line represents the glucose consumption. (B) The biomass and metabolic profiles of wild LdhA and K9R mutant overexpressed strains in lactate fermentation.
FIGURE 7K154Q-K248Q mutant inhibits lactate accumulation and improves 3HP production. (A) The synthetic pathway of lactate and 3HP from glucose. (B) The cell growth and lactate accumulation of E. coli strains carrying wild-type LdhA and LdhA double mutant, and the ldhA deleted E. coli strain. The yellow line represents the cell growth, the blue line represents the lactate production. (C) The specific growth rate of these strains. (D) The biomass and metabolic profiles of these strains in 3HP fermentation.